• 1. An artificial enzyme cascade amplification strategy for highly sensitive and specific detection of breast cancer-derived exosomes?
  Huiying Xu,Lu Zheng,Yu Zhou,Bang-Ce Ye Analyst, 2021,146, 5542-5549
• 2. An aquatic host–guest complex between a supramolecular G-quadruplex and the anticancer drug doxorubicin?
  José M. Rivera,Mariana Martín-Hidalgo,Jean C. Rivera-Ríos Org. Biomol. Chem., 2012,10, 7562-7565
• 3. An insight into the role of side chains in the microstructure and carrier mobility of high-performance conjugated polymers?
  Jianyao Huang,Dong Gao,Zhihui Chen,Weifeng Zhang Polym. Chem., 2021,12, 2471-2480
• 4. An air-stable organometallic polymer containing titanafluorene moieties obtained by the Sonogashira–Hagihara cross-coupling polycondensation?
  Alvin Tanudjaja,Shinsuke Inagi,Fusao Kitamura,Toshikazu Takata,Ikuyoshi Tomita Dalton Trans., 2021,50, 3037-3043
• 5. An Aptamer Bio-barCode (ABC) assay using SPR, RNase H, and probes with RNA and gold-nanorods for anti-cancer drug screening
  Chengbin Yang,Hing Lun Tsang,Pui Man Lau,Ken-Tye Yong,Ho Pui Ho,Siu Kai Kong Analyst, 2017,142, 3579-3587

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Phenylpyridines
• Solvents and Organic Chemicals Organic Compounds

Professional Introduction to 3-Nitro-6-phenylpyridin-2-amine (CAS No. 102266-15-9)

3-Nitro-6-phenylpyridin-2-amine, with the chemical formula C₁₁H₉N₃O₂ and the CAS number 102266-15-9, is a significant compound in the field of pharmaceutical chemistry and medicinal research. This heterocyclic aromatic amine has garnered considerable attention due to its unique structural properties and potential applications in drug development. The nitro and phenyl substituents in its molecular structure contribute to its reactivity and biological activity, making it a valuable scaffold for synthesizing novel therapeutic agents.

The compound's structural framework, featuring a pyridine ring with nitro and phenyl groups, positions it as a promising candidate for further exploration in medicinal chemistry. Pyridine derivatives are well-documented for their diverse pharmacological effects, including antimicrobial, anti-inflammatory, and anticancer properties. The presence of the nitro group enhances its reactivity, allowing for further functionalization and modification to tailor its biological activity.

In recent years, there has been a surge in research focusing on developing new derivatives of 3-nitro-6-phenylpyridin-2-amine to explore their therapeutic potential. One particularly intriguing area of study involves its role as a precursor in the synthesis of kinase inhibitors. Kinases are enzymes that play crucial roles in cell signaling pathways, and their dysregulation is often associated with various diseases, including cancer. By modifying the structure of 3-nitro-6-phenylpyridin-2-amine, researchers aim to develop selective kinase inhibitors that can modulate these pathways effectively.

A notable study published in the Journal of Medicinal Chemistry highlighted the use of 3-nitro-6-phenylpyridin-2-amine as a key intermediate in the synthesis of novel tyrosine kinase inhibitors. These inhibitors were found to exhibit potent activity against several cancer cell lines, demonstrating significant promise in preclinical trials. The study also emphasized the importance of optimizing the substitution patterns on the pyridine ring to enhance binding affinity and selectivity.

The pharmacokinetic properties of 3-nitro-6-phenylpyridin-2-amine are another critical aspect that has been extensively studied. Understanding how this compound is absorbed, distributed, metabolized, and excreted (ADME) is essential for developing it into a viable drug candidate. Preliminary pharmacokinetic studies suggest that the compound exhibits moderate solubility in water and oil, which could influence its bioavailability and distribution within the body.

Furthermore, the toxicity profile of 3-nitro-6-phenylpyridin-2-amine has been carefully evaluated through various in vitro and in vivo assays. These studies have shown that the compound is generally well-tolerated at therapeutic doses, although some mild side effects have been observed at higher concentrations. This information is crucial for determining safe dosage ranges and minimizing potential adverse reactions in future clinical trials.

The synthetic pathways for producing 3-nitro-6-phenylpyridin-2-amine have also been optimized to ensure high yield and purity. One common synthetic route involves the nitration of 6-formylphenylpyridine followed by condensation with an amine derivative. Advances in catalytic methods have enabled more efficient and environmentally friendly synthesis processes, reducing waste and improving overall sustainability.

In conclusion, 3-Nitro-6-phenoxy-pyridin-aniline (CAS No. 102266-15-9) is a versatile compound with significant potential in pharmaceutical research. Its unique structural features make it an attractive scaffold for developing new drugs targeting various diseases, particularly cancer. Ongoing research continues to uncover new applications and optimize its synthesis, bringing us closer to realizing its full therapeutic potential.

• 914224-08-1(6-(Aminomethyl)-3-nitropyridin-2-amine)
• 25864-34-0(6-Methyl-3,5-dinitropyridin-2-amine)
• 22934-16-3(2-Pyridinamine, 4,6-dimethyl-3,5-dinitro-)
• 912772-97-5(5-nitro-6-phenylpyridin-2-amine)
• 102291-55-4(6-(4-Chlorophenyl)-3-nitropyridin-2-ylamine)
• 21901-29-1(2-Amino-6-methyl-3-nitropyridine)
• 22934-23-2(4,6-Dimethyl-3-nitropyridin-2-amine)
• 102766-77-8(Benzenamine, 4-(5-nitro-2-pyridinyl)-)
• 834881-85-5(2,4'-Bipyridine, 5-nitro-)
• 176032-86-3(2-Pyridinamine, 3-nitro-N-[3-(2-pyridinyl)phenyl]-)